IN2004MU00133A - - Google Patents
Download PDFInfo
- Publication number
- IN2004MU00133A IN2004MU00133A IN133MU2004A IN2004MU00133A IN 2004MU00133 A IN2004MU00133 A IN 2004MU00133A IN 133MU2004 A IN133MU2004 A IN 133MU2004A IN 2004MU00133 A IN2004MU00133 A IN 2004MU00133A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31785001P | 2001-09-07 | 2001-09-07 | |
| US34227301P | 2001-12-21 | 2001-12-21 | |
| US38650502P | 2002-06-05 | 2002-06-05 | |
| US40383802P | 2002-08-14 | 2002-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2004MU00133A true IN2004MU00133A (es) | 2005-04-29 |
Family
ID=27502150
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN133MU2004 IN2004MU00133A (es) | 2001-09-07 | 2004-02-20 | |
| IN429MU2006 IN2006MU00429A (es) | 2001-09-07 | 2006-04-13 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN429MU2006 IN2006MU00429A (es) | 2001-09-07 | 2006-04-13 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6849736B2 (es) |
| EP (1) | EP1436295A4 (es) |
| JP (2) | JP5043286B2 (es) |
| KR (1) | KR100774271B1 (es) |
| CN (1) | CN1551880A (es) |
| CA (1) | CA2457835A1 (es) |
| CZ (1) | CZ2004446A3 (es) |
| HR (1) | HRP20040321A2 (es) |
| HU (1) | HUP0500753A3 (es) |
| IL (1) | IL160721A0 (es) |
| IN (2) | IN2004MU00133A (es) |
| MX (1) | MXPA04002192A (es) |
| NO (1) | NO20041449L (es) |
| PL (1) | PL374179A1 (es) |
| SK (1) | SK1592004A3 (es) |
| WO (1) | WO2003022209A2 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003040145A1 (en) * | 2001-11-05 | 2003-05-15 | Glaxo Group Limited | Anhydrous crystal form of valaciclovir hydrochloride |
| MX242714B (es) * | 2001-11-14 | 2006-12-15 | Teva Pharma | Sintesis y purificacion de valaciclovir. |
| WO2004000265A2 (en) * | 2002-06-24 | 2003-12-31 | Ranbaxy Laboratories Limited | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US20050043329A1 (en) * | 2002-09-06 | 2005-02-24 | Shlomit Wizel | Crystalline forms of valacyclovir hydrochloride |
| ATE335743T1 (de) * | 2002-10-16 | 2006-09-15 | Teva Pharma | Verfahren zur verminderung von restalkoholen im kristallinen valacyclovir-hydrochlorid |
| US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| US7786302B2 (en) * | 2003-05-30 | 2010-08-31 | Eczacibasi-Zentiva Kimyasal Urunler Sanayi Ve Ticaret A.S. | Crystalline forms of valacyclovir hydrochloride |
| CA2527708A1 (en) | 2003-06-02 | 2005-01-06 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of valacyclovir hydrochloride |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| EP1541133B1 (en) * | 2003-12-09 | 2005-08-10 | Helm AG | Pharmaceutical formulation of valaciclovir |
| JP2008504255A (ja) * | 2004-06-30 | 2008-02-14 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶塩酸バラシクロビル中の残留アルコールを低減する方法 |
| WO2006035452A1 (en) * | 2004-09-27 | 2006-04-06 | Matrix Laboratories Ltd | Novel pseudomorph of valaciclovir hydrochloride |
| EP1746098A1 (en) | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
| US7872075B2 (en) * | 2005-10-07 | 2011-01-18 | Exxonmobil Chemical Patents Inc. | Peroxide-cured thermoplastic vulcanizates and process for making the same |
| US20080167325A1 (en) * | 2006-12-27 | 2008-07-10 | Bs Praveen Kumar | Valacyclovir compositions |
| US20080281099A1 (en) * | 2007-05-07 | 2008-11-13 | Mayur Devjibhai Khunt | Process for purifying valacyclovir hydrochloride and intermediates thereof |
| JPWO2009031576A1 (ja) * | 2007-09-03 | 2010-12-16 | 味の素株式会社 | バラシクロビル塩酸塩結晶の製造方法 |
| US20090076039A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched valacyclovir |
| WO2011158252A1 (en) | 2010-06-15 | 2011-12-22 | Matrix Laboratories Ltd | Process for the preparation of valacyclovir hydrochloride polymorphic form ii |
| GB201222287D0 (en) * | 2012-12-11 | 2013-01-23 | Ct For Process Innovation Ltd | Methods for making active crystalline materials |
| TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途 |
| KR20200022712A (ko) * | 2018-08-23 | 2020-03-04 | 주식회사 오스코텍 | 8-브로모-2-(1-메틸피페리딘-4-일아미노)-4-(4-페녹시페닐아미노)피리도[4,3-d]피리미딘-5(6H)-온 염산염의 결정다형체 및 그 제조방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199574A (en) | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
| AP55A (en) * | 1987-08-15 | 1989-09-26 | The Wellcome Foundation Ltd | Therapeutic Acyclic Nucleosides |
| GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
| EP0702682B1 (en) * | 1993-06-10 | 2001-03-14 | Rolabo Sl | Process for the preparation of amino acid esters of nucleoside analogues |
| US5840891A (en) * | 1994-07-28 | 1998-11-24 | Syntex (U.S.A.) Inc. | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative |
| GB9501178D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Guanine derivative |
| CA2243237C (en) * | 1996-01-19 | 2008-09-02 | Glaxo Group Limited | Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| AU1592897A (en) * | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
| US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| US6040446A (en) * | 1996-01-26 | 2000-03-21 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative |
| IT1283447B1 (it) * | 1996-07-18 | 1998-04-21 | Ind Chimica Srl | Processo di preparazione del valaciclovir e relativi intermedi |
| WO2003040145A1 (en) * | 2001-11-05 | 2003-05-15 | Glaxo Group Limited | Anhydrous crystal form of valaciclovir hydrochloride |
| MX242714B (es) * | 2001-11-14 | 2006-12-15 | Teva Pharma | Sintesis y purificacion de valaciclovir. |
| WO2004000265A2 (en) * | 2002-06-24 | 2003-12-31 | Ranbaxy Laboratories Limited | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
| AU2003289995A1 (en) * | 2002-12-09 | 2004-06-30 | Texcontor Etablissement | Anhydrous crystalline form of valacyclovir hydrochloride |
| US7786302B2 (en) * | 2003-05-30 | 2010-08-31 | Eczacibasi-Zentiva Kimyasal Urunler Sanayi Ve Ticaret A.S. | Crystalline forms of valacyclovir hydrochloride |
| EP1746098A1 (en) * | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
| US20070112193A1 (en) * | 2005-11-14 | 2007-05-17 | Khunt Mayur D | Valacyclovir process |
-
2002
- 2002-09-06 WO PCT/US2002/028517 patent/WO2003022209A2/en active Application Filing
- 2002-09-06 EP EP02759585A patent/EP1436295A4/en not_active Withdrawn
- 2002-09-06 CA CA002457835A patent/CA2457835A1/en not_active Abandoned
- 2002-09-06 SK SK159-2004A patent/SK1592004A3/sk not_active Application Discontinuation
- 2002-09-06 CZ CZ2004446A patent/CZ2004446A3/cs unknown
- 2002-09-06 JP JP2003526339A patent/JP5043286B2/ja not_active Expired - Fee Related
- 2002-09-06 HU HU0500753A patent/HUP0500753A3/hu unknown
- 2002-09-06 CN CNA028174143A patent/CN1551880A/zh active Pending
- 2002-09-06 IL IL16072102A patent/IL160721A0/xx unknown
- 2002-09-06 US US10/236,729 patent/US6849736B2/en not_active Expired - Fee Related
- 2002-09-06 KR KR20047003301A patent/KR100774271B1/ko not_active IP Right Cessation
- 2002-09-06 PL PL02374179A patent/PL374179A1/xx not_active Application Discontinuation
- 2002-09-06 MX MXPA04002192A patent/MXPA04002192A/es active IP Right Grant
-
2004
- 2004-02-20 IN IN133MU2004 patent/IN2004MU00133A/en unknown
- 2004-04-05 HR HR20040321A patent/HRP20040321A2/hr not_active Application Discontinuation
- 2004-04-06 NO NO20041449A patent/NO20041449L/no not_active Application Discontinuation
-
2005
- 2005-01-25 US US11/042,526 patent/US20050187229A1/en not_active Abandoned
-
2006
- 2006-04-13 IN IN429MU2006 patent/IN2006MU00429A/en unknown
-
2012
- 2012-05-17 JP JP2012113743A patent/JP2012162565A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2004446A3 (cs) | 2005-01-12 |
| MXPA04002192A (es) | 2005-02-17 |
| CA2457835A1 (en) | 2003-03-20 |
| HUP0500753A2 (hu) | 2005-11-28 |
| SK1592004A3 (sk) | 2005-03-04 |
| EP1436295A2 (en) | 2004-07-14 |
| JP5043286B2 (ja) | 2012-10-10 |
| WO2003022209A3 (en) | 2003-11-27 |
| KR20040036932A (ko) | 2004-05-03 |
| EP1436295A4 (en) | 2007-07-11 |
| IN2006MU00429A (es) | 2007-08-17 |
| WO2003022209A2 (en) | 2003-03-20 |
| HRP20040321A2 (en) | 2004-08-31 |
| JP2012162565A (ja) | 2012-08-30 |
| KR100774271B1 (ko) | 2007-11-08 |
| HUP0500753A3 (en) | 2006-05-29 |
| WO2003022209A9 (en) | 2004-04-08 |
| IL160721A0 (en) | 2004-08-31 |
| US20030114470A1 (en) | 2003-06-19 |
| JP2005526694A (ja) | 2005-09-08 |
| NO20041449L (no) | 2004-04-06 |
| PL374179A1 (en) | 2005-10-03 |
| US6849736B2 (en) | 2005-02-01 |
| US20050187229A1 (en) | 2005-08-25 |
| CN1551880A (zh) | 2004-12-01 |